AEON Biopharma (AEON Biopharma) EV-to-EBITDA : -3.76 (As of May. 16, 2024)

AEON Biopharma EV-to-EBITDA Chart

AEON Biopharma Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Sep22	Dec22	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial				-	-	-	-12.80	-

Competitive Comparison of AEON Biopharma's EV-to-EBITDA

For the Biotechnology subindustry, AEON Biopharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AEON Biopharma's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEON Biopharma's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AEON Biopharma's EV-to-EBITDA falls into.

AEON Biopharma EV-to-EBITDA Calculation

AEON Biopharma's EV-to-EBITDA for today is calculated as:

AEON Biopharma's current Enterprise Value is $56.40 Mil.
AEON Biopharma's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AEON Biopharma  (AMEX:AEON) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AEON Biopharma's PE Ratio for today is calculated as:

AEON Biopharma's share price for today is $1.50.
AEON Biopharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.571.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

AEON Biopharma EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AEON Biopharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

AEON Biopharma (AEON Biopharma) Business Description